Amyotrophic lateral sclerosis - SAR443820 TS ID 11938Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Audit of Motor Neurone Disease (MND) multidisciplinary team clinic services against NICE guidelines in a University Health BoardProduct type:Shared learningPublished: 13 October 2017
Audit proposal to address cough augmentation for people with Motor Neurone Disease (MND) - a shared resource toolProduct type:Shared learningPublished: 18 October 2018
Development of a multidisciplinary respiratory assessment tool to facilitate early identification of respiratory impairment in clients with motor neurone diseaseProduct type:Shared learningPublished: 1 February 2018
Edaravone for treating amyotrophic lateral sclerosis TS ID 11869Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Getting it right first time: developing a standard approach to care for people living with Motor Neurone Disease in Greater ManchesterProduct type:Shared learningPublished: 4 November 2020
Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease (TA20)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 January 2001
Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone disease (IPG593)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 September 2017
Long Term Case Management of patients with Motor Neurone Disease within a Community Neurological Rehabilitation Team: A review of quality care within WolverhamptonProduct type:Shared learningPublished: 31 January 2019
Masitinib with riluzole for treating amyotrophic lateral sclerosis ID6257Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Motor neurone disease: assessment and management (NG42)Product type:GuidanceProgramme:NICE guidelineLast updated: 23 July 2019Published: 24 February 2016
Pegcetacoplan for amyotrophic lateral sclerosis TS ID 10594Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Riluzole oral film for treating amyotrophic lateral sclerosis TS ID 11779Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Sodium phenylbutyrate–ursodoxicoltaurine for treating amyotrophic lateral sclerosis [ID6246]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs (MIB159)Product type:AdviceProgramme:Medtech innovation briefingPublished: 14 September 2018